Company filings profile · CIK 0001659617

Moleculin Biotech, Inc. — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for Moleculin Biotech, Inc. (MBRX): 29 filings in the last 90 days vs 17 in the prior 90 (filing-velocity rising ↑ · 1.71×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Sep 19, 2026. Source-linked, daily-refreshed.

Material 8-K events — Moleculin Biotech, Inc.

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
Sep 18, 2026Delisting / Listing-Rule Failure
Sep 14, 2026Regulation FD Disclosure; Financial Statements and Exhibits
Aug 31, 2026Regulation FD Disclosure; Financial Statements and Exhibits
Aug 14, 2026Results of Operations (earnings); Financial Statements and Exhibits
Aug 3, 2026Entry into a Material Agreement; Financial Statements and Exhibits
Jul 31, 2026Regulation FD Disclosure; Financial Statements and Exhibits
Jun 30, 2026Regulation FD Disclosure; Financial Statements and Exhibits
Jun 30, 2026Regulation FD Disclosure; Financial Statements and Exhibits
Jun 5, 2026Regulation FD Disclosure; Financial Statements and Exhibits
May 29, 2026Regulation FD Disclosure; Financial Statements and Exhibits
May 26, 2026Regulation FD Disclosure; Financial Statements and Exhibits
May 22, 2026Regulation FD Disclosure; Financial Statements and Exhibits
May 15, 2026Results of Operations (earnings); Financial Statements and Exhibits
May 13, 2026Regulation FD Disclosure; Financial Statements and Exhibits
May 12, 2026Regulation FD Disclosure; Financial Statements and Exhibits

Watch Moleculin Biotech, Inc. automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Insider transactions (Form 4 / 3 / 5)

FiledForm
Aug 5, 20264
Aug 5, 20264
Aug 5, 20264
Jun 24, 20264
Jun 24, 20264
Jun 24, 20264

Recent filings

FiledFormDetail
Sep 18, 20268-K Delisting / Listing-Rule Failure
Sep 14, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
Aug 31, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
Aug 25, 2026SCHEDULE 13D
Aug 25, 2026SCHEDULE 13D
Aug 24, 2026DEFA14A FORM DEFA14A
Aug 24, 2026DEF 14A FORM DEF 14A
Aug 21, 2026424B5 FORM 424B5
Aug 14, 2026PRE 14A FORM PRE 14A
Aug 14, 20268-K Results of Operations (earnings); Financial Statements and Exhibits
Aug 13, 202610-Q FORM 10-Q
Aug 10, 2026SCHEDULE 13G
Aug 6, 2026SCHEDULE 13G
Aug 5, 20264 FORM 4
Aug 5, 20264 FORM 4
Aug 5, 20264 FORM 4
Aug 3, 20268-K Entry into a Material Agreement; Financial Statements and Exhibits
Aug 3, 2026424B5 FORM 424B5
Jul 31, 2026EFFECT Item ; Item ; Item
Jul 31, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
Jul 31, 2026S-1/A FORM S-1/A
Jul 30, 2026S-1/A FORM S-1/A
Jul 29, 2026S-1 FORM S-1
Jul 15, 2026DRS
Jun 30, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
Jun 30, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
Jun 24, 20264 FORM 4
Jun 24, 20264 FORM 4
Jun 24, 20264 FORM 4
Jun 5, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
May 29, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
May 26, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
May 22, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
May 15, 20268-K Results of Operations (earnings); Financial Statements and Exhibits
May 14, 202610-Q FORM 10-Q
May 13, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
May 12, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
May 8, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
Apr 23, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
Apr 15, 20268-K Item 5.07